{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:16:17Z","timestamp":1788383777048,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.soc.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:55:52Z","timestamp":1781726152000},"page":"765-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Bone Tumors"],"prefix":"10.1016","volume":"35","author":[{"given":"Thomas J.","family":"Scharschmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odion","family":"Binitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.soc.2026.04.010_bib1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.soc.2026.04.010_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2026.04.010_bib3","series-title":"Osteosarcoma. Atlas of orthopedic pathology","first-page":"179","author":"Wold","year":"2008"},{"issue":"11","key":"10.1016\/j.soc.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/cncr.34163","article-title":"Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017","volume":"128","author":"Cole","year":"2022","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.soc.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/cncr.25734","article-title":"Radiation-induced osteosarcomas of the calvarium and skull base","volume":"117","author":"Patel","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2026.04.010_bib6","series-title":"Perez and Brady\u2019s principles and practice of radiation oncology","author":"Halperin","year":"2008"},{"issue":"10","key":"10.1016\/j.soc.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.radcr.2023.07.076","article-title":"Radiation-induced osteosarcoma of the chest wall after treatment for unresectable thymoma","volume":"18","author":"Venkatraman","year":"2023","journal-title":"Radiol Case Reports"},{"issue":"Suppl 2","key":"10.1016\/j.soc.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"P58","DOI":"10.1359\/jbmr.06s211","article-title":"Osteosarcoma in Paget\u2019s disease of bone","volume":"21","author":"Hansen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.soc.2026.04.010_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.blo.0000180053.99840.27","article-title":"Paget\u2019s sarcoma: a historical and outcome review","volume":"438","author":"Mankin","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.soc.2026.04.010_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/00003086-198803000-00046","article-title":"Malignant transformation of fibrous dysplasia A case report and review of the literature","volume":"228","author":"Yabut","year":"1988","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"10.1016\/j.soc.2026.04.010_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31362","article-title":"Li-Fraumeni-associated osteosarcomas: the French experience","volume":"71","author":"Saucier","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.soc.2026.04.010_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcped.2024.100158","article-title":"Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)","volume":"3","author":"Bielack","year":"2024","journal-title":"EJC Paediatric Oncology"},{"issue":"16","key":"10.1016\/j.soc.2026.04.010_bib13","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: a report from the diamond blackfan anemia registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13577140410001679266","article-title":"Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy","volume":"8","author":"Lee","year":"2004","journal-title":"Sarcoma"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1200\/JCO.2006.08.4558","article-title":"Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome","volume":"25","author":"Hicks","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/08880018.2012.668748","article-title":"Osteosarcoma following growth hormone therapy in recurrent acute lymphoblastic leukemia and rapadilino syndrome","volume":"29","author":"Sandoval","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.soc.2026.04.010_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1349-7006.2000.tb00924.x","article-title":"Atypical osteosarcomas in Werner Syndrome (adult progeria)","volume":"91","author":"Ishikawa","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.soc.2026.04.010_bib18","series-title":"Osteosarcoma","first-page":"59","article-title":"Osteosarcoma in the elderly: clinical features and outcome","author":"Nishida","year":"2016"},{"key":"10.1016\/j.soc.2026.04.010_bib19","series-title":"Parosteal osteosarcoma. Bone tumors","first-page":"73","author":"Yaghmai","year":"1977"},{"issue":"8","key":"10.1016\/j.soc.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/cncr.25718","article-title":"Periosteal osteosarcoma: a single-institution experience","volume":"117","author":"Cesari","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17040599","article-title":"Multimodal imaging of osteosarcoma: from first diagnosis to radiomics","volume":"17","author":"C\u00e8","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib22","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1148\/rg.210171","article-title":"Pediatric osteosarcoma: correlation of imaging findings with histopathologic features, treatment, and outcome","volume":"42","author":"Nguyen","year":"2022","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.soc.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2967\/jnumed.123.265592","article-title":"F-FDG PET\/CT in the management of osteosarcoma","volume":"64","author":"Oh","year":"2023","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.soc.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/1097-0142(20001215)89:12<2677::AID-CNCR22>3.0.CO;2-L","article-title":"The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses: outcomes analysis of 155 patients at a sarcoma referral center","volume":"89","author":"Welker","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2026.04.010_bib25","series-title":"Who\u2019s who in orthopedics","first-page":"161","article-title":"Jaffe 1896\u20131979","author":"Henry","year":"2005"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1302\/0301-620X.106B1.BJJ-2023-0531.R1","article-title":"Diagnostic challenges in low-grade central osteosarcoma: a retrospective study","volume":"106","author":"Khal","year":"2024","journal-title":"Bone Jt J"},{"issue":"2","key":"10.1016\/j.soc.2026.04.010_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11999-016-5090-y","article-title":"Are biopsy tracts a concern for seeding and local recurrence in sarcomas?","volume":"475","author":"Barrientos-Ruiz","year":"2017","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib28","article-title":"Optimizing ewing sarcoma and osteosarcoma biopsy acquisition: a children\u2019s oncology group bone tumor committee consensus statement","volume":"23","author":"Dietz","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"issue":"9","key":"10.1016\/j.soc.2026.04.010_bib29","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2005.06.031","article-title":"Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and\/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate","volume":"23","author":"Meyers","year":"2005","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.soc.2026.04.010_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316823","article-title":"The future of HER2-Targeted treatment for osteosarcoma: lessons from the negative trastuzumab deruxtecan results","volume":"24","author":"Nakano","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.soc.2026.04.010_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(16)30096-1","article-title":"Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Piperno-Neumann","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2026.04.010_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djk015","article-title":"Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup","volume":"99","author":"Lewis","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib33","article-title":"Ninety percent or greater tumor necrosis is associated with survival and social determinants of health in patients with osteosarcoma in the national cancer database clinical orthopaedics and related research\u00ae","volume":"481","author":"Richardson","year":"2023"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2026.04.010_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00625047","article-title":"Morphological grades of regression in osteosarcoma after Polychemotherapy\u2014study COSS 80","volume":"106","author":"Salzer-Kuntschik","year":"1983","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2026.04.010_bib35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6","article-title":"Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor","volume":"56","author":"Picci","year":"1985","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.soc.2026.04.010_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.5858\/arpa.2015-0389-OA","article-title":"Histopathologic features of prognostic significance in high-grade osteosarcoma","volume":"140","author":"Chui","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31471","article-title":"Outcomes based on histological tumor necrosis and predictive clinical and laboratory parameters for necrosis in children with osteosarcoma treated on a non-high dose methotrexate-based chemotherapy backbone","volume":"72","author":"Parambil","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib39","first-page":"359","article-title":"Inter-and intra-observer reliability in histologic evaluation of necrosis rate induced by neo-adjuvant chemotherapy for osteosarcoma","volume":"10","author":"Kang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajpath.2022.12.004","article-title":"Deep learning-based objective and reproducible osteosarcoma chemotherapy response assessment and outcome prediction","volume":"193","author":"Ho","year":"2023","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.soc.2026.04.010_bib41","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100362","article-title":"Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy \u2013 observational prospective single institution analysis","volume":"28","author":"M\u00fadry","year":"2021","journal-title":"J Bone Oncol"},{"issue":"28","key":"10.1016\/j.soc.2026.04.010_bib43","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO-25-00210","article-title":"Is there a role for mifamurtide in nonmetastatic high-grade osteosarcoma? Results From the Italian Sarcoma Group (ISG\/OS-2) and Spanish sarcoma Group (GEIS-33) trials","volume":"43","author":"Palmerini","year":"2025","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2026.04.010_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31834","article-title":"Local control and toxicity outcomes after stereotactic body radiation therapy for metastatic osteosarcoma in pediatric patients","volume":"72","author":"Reddy","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"1, Supplement","key":"10.1016\/j.soc.2026.04.010_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.06.3664","article-title":"Proton therapy for pediatric patients with localized unresectable osteosarcoma","volume":"123","author":"Indelicato","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2026.04.010_bib46","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002324","article-title":"Osteosarcoma: current insights and advances","volume":"6","author":"Brar","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2008.06.1007","article-title":"Carbon ion radiotherapy for unresectable primary bone sarcoma of the spine","volume":"72","author":"Kamada","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2026.04.010_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2021.01.029","article-title":"The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma","volume":"159","author":"Seidensaal","year":"2021","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejca.2004.11.012","article-title":"Management and outcome after local recurrence of osteosarcoma","volume":"41","author":"Grimer","year":"2005","journal-title":"Eur J Cancer"},{"issue":"20","key":"10.1016\/j.soc.2026.04.010_bib50","doi-asserted-by":"crossref","first-page":"20231","DOI":"10.1002\/cam4.6491","article-title":"Survival outcomes and surgical morbidity based on surgical approach to pulmonary metastasectomy in pediatric, adolescent and young adult patients with osteosarcoma","volume":"12","author":"Kuo","year":"2023","journal-title":"Cancer Med"},{"issue":"13","key":"10.1016\/j.soc.2026.04.010_bib51","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1245\/s10434-022-12488-y","article-title":"A phase III, randomized, controlled trial comparing open versus thoracoscopic management of pulmonary metastases in patients with osteosarcoma","volume":"29","author":"Teke","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100511","article-title":"Tyrosine kinase inhibitors in osteosarcoma: adapting treatment strategiesa","volume":"43","author":"Assi","year":"2023","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib53","unstructured":"Children's Oncology Group (COG). A study to test the addition of the drug cabozantinib to standard chemotherapy in patients with newly diagnosed osteosarcoma [Internet]. Bethesda (MD): National Library of Medicine (US); 2023. Available at: https:\/\/clinicaltrials.gov\/study\/NCT05691478 (Accessed 1 June 2026)."},{"issue":"16_suppl","key":"10.1016\/j.soc.2026.04.010_bib54","doi-asserted-by":"crossref","first-page":"TPS10060","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS10060","article-title":"CaboMain: a phase 2 study of cabozantinib as a maintenance agent in patients with ultra-high risk pediatric solid tumors","volume":"40","author":"Shah","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib55","unstructured":"Ipsen Pharma. A phase II, randomized, open-label study to assess the efficacy, safety, and pharmacokinetics (PK) of maintenance cabozantinib (XL184) plus best supportive care (BSC) versus BSC in children, adolescents and young adults (AYA) with unresectable residual osteosarcoma either at diagnosis or at first relapse after standard treatment (CabOSTar). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2024. Available at: https:\/\/clinicaltrials.gov\/study\/NCT06341712."},{"key":"10.1016\/j.soc.2026.04.010_bib56","article-title":"Recurrent and refractory ewing sarcoma phase I\/II trials: current perspective from the euro-ewing consortium","volume":"9","author":"Juan Ribelles","year":"2025","journal-title":"JCO Precision Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.soc.2026.04.010_bib57","article-title":"Ewing sarcoma","volume":"68","author":"Eaton","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"10362","key":"10.1016\/j.soc.2026.04.010_bib58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(22)01790-1","article-title":"Comparison of two chemotherapy regimens in patients with newly diagnosed ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial","volume":"400","author":"Brennan","year":"2022","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.soc.2026.04.010_bib59","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO-25-00157","article-title":"Molecular characterization informs prognosis in patients with localized ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"43","author":"Gillani","year":"2025","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13014-025-02743-3","article-title":"Optimizing local control in Ewing sarcoma: a critical discussion of radiotherapy and surgical approaches with proposed decision-making algorithm; a narrative review","volume":"20","author":"Jamshidi","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31374","article-title":"Contemporary surgical management of osteosarcoma and Ewing sarcoma","volume":"72","author":"Callan","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.soc.2026.04.010_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2024.01.007","article-title":"Updates on WHO classification for small round cell tumors: ewing sarcoma vs. everything else","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.soc.2026.04.010_bib63","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s41416-022-01977-2","article-title":"Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma","volume":"127","author":"Shulman","year":"2022","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.suronc.2018.07.016","article-title":"Prognostic factors for survival in Ewing sarcoma: a systematic review","volume":"27","author":"Bosma","year":"2018","journal-title":"Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2026.04.010_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31820","article-title":"Preoperative radiotherapy in patients with localized ewing sarcoma enrolled on AEWS1031: a report from the Children\u2019s Oncology Group","volume":"72","author":"Indelicato","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorep.2024.100502","article-title":"Pathological fracture characteristics and their impact on osteosarcoma prognosis: a systematic review","volume":"4","author":"Warikoo","year":"2025","journal-title":"Journal of Orthopaedic Reports"},{"issue":"12","key":"10.1016\/j.soc.2026.04.010_bib67","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/CORR.0000000000002687","article-title":"Are pathologic fractures in patients with osteosarcoma associated with worse survival outcomes? A systematic review and meta-analysis","volume":"481","author":"Gonzalez","year":"2023","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.soc.2026.04.010_bib68","series-title":"DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles & Practice of Oncology","first-page":"1450","article-title":"Sarcomas of bone","author":"O\u2019Donnell","year":"2019"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12893-025-02828-6","article-title":"Vascularized fibular epiphyseal transfer for biological reconstruction of bone defects following resection in children with proximal humeral sarcoma","volume":"25","author":"Li","year":"2025","journal-title":"BMC Surg"},{"issue":"4","key":"10.1016\/j.soc.2026.04.010_bib70","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PRS.0000000000010001","article-title":"Outcomes following free fibula physeal transfer for pediatric proximal humerus reconstruction: an international multi-institutional study","volume":"151","author":"Azoury","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.soc.2026.04.010_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/CORR.0000000000002969","article-title":"What is the revision-free survival of resurfaced allograft-prosthesis composites for proximal humerus reconstruction in children with bone tumors?","volume":"482","author":"Costantino","year":"2024","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib72","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s40001-025-03007-2","article-title":"Enhanced clinical outcomes of uncemented prostheses in revision surgery of distal femoral tumor prostheses: a retrospective study","volume":"30","author":"Peng","year":"2025","journal-title":"Eur J Med Res"},{"issue":"9","key":"10.1016\/j.soc.2026.04.010_bib73","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1302\/0301-620X.106B9.BJJ-2024-0109.R1","article-title":"Survivorship, complications, and functional outcomes of uncemented distal femoral endoprosthesis with short, curved stem for patients with bone tumours","volume":"106-B","author":"Gong","year":"2024","journal-title":"Bone Jt J"},{"issue":"11","key":"10.1016\/j.soc.2026.04.010_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/CORR.0000000000003543","article-title":"Is proximal tibial hemiarthroplasty reconstruction effective in minimizing limb length discrepancy among skeletally immature patients with primary bone sarcomas?","volume":"483","author":"Li","year":"2025","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.soc.2026.04.010_bib75","series-title":"3D Printing at Hospitals and Medical Centers: A Practical Guide for Medical Professionals","first-page":"105","article-title":"Musculoskeletal 3D printing","author":"Gupta","year":"2024"},{"key":"10.1016\/j.soc.2026.04.010_bib76","first-page":"10","article-title":"Intercalary reconstruction of long bones by massive allograft: Comparison of construct stability ensured by three different host-graft junctions and two types of fixations in a synthetic femur model","author":"Baleani","year":"2022","journal-title":"Frontiers in Pediatrics. [Original Research]"},{"issue":"2","key":"10.1016\/j.soc.2026.04.010_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2106\/JBJS.23.01462","article-title":"3D-Printed prosthesis with an articular interface for anatomical acetabular reconstruction after type I + II (+ III) internal hemipelvectomy: clinical outcomes and finite element analysis","volume":"107","author":"Huang","year":"2025","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"10.1016\/j.soc.2026.04.010_bib79","doi-asserted-by":"crossref","DOI":"10.1097\/CORR.0000000000003495","article-title":"Is rotationplasty still a reasonable reconstruction option for patients with a femoral bone sarcoma? A comparative study of patients with a minimum of 20 years of Follow-up after rotationplasty and lower extremity amputation","volume":"483","author":"Hobusch","year":"2025","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"10.1016\/j.soc.2026.04.010_bib80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004020000175","article-title":"Rotationplasty \u2013 surgical treatment modality after failed limb salvage procedure","volume":"120","author":"Hillmann","year":"2000","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"10.1016\/j.soc.2026.04.010_bib81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jso.25586","article-title":"Targeted muscle reinnervation in oncologic amputees: early experience of a novel institutional protocol","volume":"120","author":"Alexander","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib82","unstructured":"Onkos Surgical, Inc. De Novo classification request for ELEOS\u2122 and ELEOSx\u2122 limb salvage system. DEN210058. U.S. Food and Drug Administration. 2022. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN210058.pdf [1, 2] (Accessed 1 June 2026)."},{"issue":"2","key":"10.1016\/j.soc.2026.04.010_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1302\/0301-620X.97B2.34554","article-title":"Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients","volume":"97-B","author":"Wafa","year":"2015","journal-title":"Bone Jt J"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2026.04.010_bib84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2106\/JBJS.22.01185","article-title":"Does the use of negative pressure wound therapy and postoperative drains impact the development of surgical site infections?: a PARITY trial secondary analysis","volume":"105","author":"LiBrizzi","year":"2023","journal-title":"JBJS"},{"key":"10.1016\/j.soc.2026.04.010_bib85","article-title":"Bad to the bone: emerging approaches to aggressive bone sarcomas","volume":"43","author":"Wood","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.soc.2026.04.010_bib86","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.jbo.2022.100466","article-title":"Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment","volume":"38","author":"Goedhart","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib87","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-026-04261-4","article-title":"Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease","author":"Linder-Stragliotto","year":"2026","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib88","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1200\/JCO.2024.42.16_suppl.11507","article-title":"ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma","volume":"42","author":"Xie","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2026.04.010_bib89","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12672-025-02208-9","article-title":"Systemic strategies for osteosarcoma: advances and future directions","volume":"16","author":"Morya","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.soc.2026.04.010_bib90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jor.2024.10.012","article-title":"Surgeon perspectives on a virtual reality platform for preoperative planning in complex bone sarcomas","volume":"62","author":"Vucicevic","year":"2024","journal-title":"J Orthop"},{"key":"10.1016\/j.soc.2026.04.010_bib91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1302\/0301-620X.107B5.BJJ-2024-0732.R2","article-title":"Long-term outcomes of computer navigation-assisted resection for primary pelvic sarcomas","volume":"107","author":"Li","year":"2025","journal-title":"Bone Joint J"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320726000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320726000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:25:15Z","timestamp":1788380715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320726000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1055320726000359"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2026.04.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Bone Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}